Publicaciones (204) Publicaciones de JOSE ESTEBAN JODAR GIMENO

2024

  1. Adherence and Persistence to Basal Insulin Among People with Type 2 Diabetes in Europe: A Systematic Literature Review and Meta-analysis

    Diabetes Therapy

  2. Efficacy and Safety of Calcifediol in Young Adults with Vitamin D Deficiency: A Phase I, Multicentre, Clinical Trial—POSCAL Study

    Nutrients, Vol. 16, Núm. 2

2023

  1. Calcifediol: a review of its pharmacological characteristics and clinical use in correcting vitamin D deficiency

    European Journal of Nutrition, Vol. 62, Núm. 4, pp. 1579-1597

  2. Comprehensive approach to people with type 2 diabetes. Diabetes Knowledge Area of the Spanish Society of Endocrinology and Nutrition

    Endocrinologia, Diabetes y Nutricion, Vol. 70, pp. 95-102

  3. Impact of fragility fractures in postmenopausal Spanish women with osteoporosis

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 15, Núm. 4, pp. 135-143

  4. Long-Term Treatment and Effect of Discontinuation of Calcifediol in Postmenopausal Women with Vitamin D Deficiency: A Randomized Trial

    Journal of Bone and Mineral Research, Vol. 38, Núm. 4, pp. 471-479

  5. Psychometric properties of the Clarke questionnaire for hypoglycemia awareness in the Spanish population with type 2 diabetes

    Postgraduate Medicine, Vol. 135, Núm. 2, pp. 141-148

  6. Two-year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5

    Obesity, Vol. 31, Núm. 3, pp. 703-715

2022

  1. Benefits of SGLT2i for the Treatment of Heart Failure Irrespective of Diabetes Diagnosis: A State-of-the-Art Review

    Diabetes Therapy, Vol. 13, pp. 19-34

  2. Delphi Consensus on Therapeutic Strategies and Health Prevention of hypovitaminosis D

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 4, pp. 115-124

  3. Effective Overall Glycaemic Control with Fast-Acting Insulin Aspart Across Patients with Different Baseline Characteristics: A Post Hoc Analysis of the Onset 9 Trial

    Diabetes Therapy, Vol. 13, Núm. 4, pp. 761-774

  4. Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis (2022 update)

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 1, pp. 5-12

  5. Glycaemic variability in patients with type 2 diabetes mellitus treated with dulaglutide, with and without concomitant insulin: Post hoc analyses of randomized clinical trials

    Diabetes, Obesity and Metabolism, Vol. 24, Núm. 4, pp. 631-640

  6. Guidelines on the management of mineral and bone metabolism disorders during pregnancy and lactation

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 7, pp. 530-539

  7. Reply to Calcifediol Is Not Superior to Cholecalciferol in Improving Vitamin D Status in Postmenopausal Women

    Journal of Bone and Mineral Research

  8. Romosozumab efficacy and safety in European patients enrolled in the FRAME trial

    Osteoporosis International, Vol. 33, Núm. 12, pp. 2527-2536

  9. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial

    Nature Medicine, Vol. 28, Núm. 10, pp. 2083-2091

2021

  1. Calcifediol is superior to cholecalciferol in improving vitamin D status in postmenopausal women: a randomized trial

    Journal of Bone and Mineral Research, Vol. 36, Núm. 10, pp. 1967-1978

  2. Coexistence of dyschondrosteosis associated to SHOX deficiency, pseudohypoparathyroidism 1B, and chronic autoimmune thyroiditis: A case report

    Journal of Pediatric Endocrinology and Metabolism, Vol. 34, Núm. 4, pp. 531-534

  3. Executive summary: Position document: Evaluation and management of hypoglycemia in the patient with diabetes mellitus 2020. Diabetes Mellitus Working Group of the Spanish Society of Endocrinology and Nutrition

    Endocrinologia, Diabetes y Nutricion, Vol. 68, Núm. 4, pp. 270-276